Publicaciones científicas

New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis

de Moreno R (1), Redondo C (2), Pérez-Davó A (3), Moreno E(4), Redondo P (5).

(1) Department of Dermatology, Hospital Universitario La Paz, 28046 Madrid, Spain.
(2) Dermatology Group Pedro Jaén, 28002 Madrid, Spain.
(3) Medical Affairs Department, Cantabria labs, 28043 Madrid, Spain.
(4) Department of Dermatology, Clínica Universitaria de Navarra, 31008 Pamplona, Spain.
(5) Department of Dermatology, Clínica Universitaria de Navarra, 31008 Pamplona, Spain.

Revista: Children (Basel)

Fecha: 29-ene-2019

Dermatología

RESUMEN

Atopic dermatitis (AD) is a chronic cutaneous inflammatory disorder, characterized by skin barrier disruption.

Dermacare is a new cosmetic formulation, which enhances moisturization, reinforces and repairs the skin barrier, and prevents cutaneous microbiota imbalance. To demonstrate its safety and efficacy, a prospective, open-label, and multicenter study was carried out on patients diagnosed with mild to moderate AD.

Transepidermal water loss (TEWL), clinical severity, Desquamation Index, Patient/Investigator Global Assessments, quality of life index, and tolerance were assessed. Adverse events were recorded.

Daily application of the new treatment was well tolerated, and adverse events were absent. After 14 days, TEWL showed a 36.7% significant decrease (p = 0.035). At the end of the 28-day treatment, the Desquamation Index showed a reduction in 70% of patients; Eczema Area and Severity Index were reduced by 70.4% (p = 0.002); and skin irritation showed a significant reduction (p = 0.024). Likewise, Patient and Investigator Global Assessments reported a significant improvement in conditions and an overall global worsening when patients restarted their normal treatment.

Parent's Index of Quality of Life Index significantly increased by 36.4% (p < 0.05) with Dermacare. In conclusion, a regular use of this new formulation can reduce the risk of relapse and extend the steroid-free treatment periods.

CITA DEL ARTÍCULO  Children (Basel). 2019 Jan 29;6(2). pii: E17. doi: 10.3390/children6020017

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra